Novel Gene Therapy
chronic ischemia
Treatment of Ischemia
novel endogenetherapy approach
new platform technology
development of new technology
release of promoter
gene clusters
severe myocardial ischemia
new era
promoter-targeted ncRNAs
invasive new treatment
new promoter-targeted upregulating short hairpinRNAs
novel concept
Concepts of endogenetherapy
Activation of Endogenous Genes
clear lack of technology capable of targeted upregulation of endogenous genes
specific CRISPR
specific transcription centers
developed chronic cardiac ischemia model
endogenous VEGF
C genes
angiogenic transcription programs
gene transfer of exogenous cDNA
gRNAmutatedCas9-VP16 technology
tissue-specific superenhancerRNAs
nuclear RNAi Background
nuclear RNAi vectors
natural angiogenic programs
small circularRNAs
small molecules
large number of patients
Therapeutic angiogenesis
pigs
vascular endothelial growth factors
different chromosomal regions
metabolites
functional outcomes
native promoters
ultrasound
MRI
relevant blood flow
analysis
VEGFs
integration
ability
special emphasis
PET imaging
clinical study
paradigm shift
self-splicing exons-introns
areas of medicine
genomic safe harbor sites
great potential
best construct
cardiovascular diseases
mice
oligonucleotides
phase
epigenetic changes
biomedical research
tissues
preclinical studies
Significance